News

Over 150 oncologists choose their preference for combination regimens in metastatic ccRCC based on current data in the ...
A study compares second-look laparoscopy and circulating tumor DNA (ctDNA) to detect residual ovarian cancer and predict ...
Shifting from a tumor-centric to a patient-centric approach is key for older cancer patients, focusing on functional capacity ...
Innovent's bispecific antibody, IBI363, enters a global phase 3 trial for IO-resistant lung cancer, the first of its kind, ...